The University of Tennessee Health Science Center is requesting funds to purchase a new 400 MHz NMR spectrometer that will replace our 17-year old Bruker ARX-300 MHz NMR. Together with a well equipped 500 MHz instrument for advanced NMR experiments, this instrument will be managed within the campus's Shared NMR Facility. This instrument will support many on-going, NIH funded research projects that mainly focus on small molecular drug discovery and drug delivery. The 300 MHz NMR has been used for routine NMR studies in a walk-up mode. The requested new, simple two-channel solution 400 MHz NMR is needed to replace the aging and technically limited 300 NMR. It will be equipped with a basic sample changer and one broadband probe that automatically tune to nuclei usually encountered in medicinal chemistry (1H, 19F, 13C, 31P and 15N). It offers significantly greater sensitivity, higher throughput, and substantially better performance compared with the old 300 NMR that it replaces. It will also provide capability for automated, routine two dimensional NMR measurements for medicinal chemists, freeing up valuable instrument time on the 500 MHz NMR which is needed for many advanced experiments for on-going and expanded NIH supported projects. The actively shielded magnet has greatly reduced stray field which will allow us to make better use of valuable lab space. Several drug candidates discovered through NIH funded research on this campus have been licensed and are in the commercialization process. The acquisition of the new 400 MHz will enhance NIH funded biomedical research and the training of graduate students substantially. The University of Tennessee Health Science Center has strong commitment to support biomedical research, as evidenced by the fact that both current NMR instruments were purchased and well maintained with funds from the university.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BCMB-N (30))
Program Officer
Birken, Steven
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Tennessee Health Science Center
Schools of Pharmacy
United States
Zip Code
Slominski, Andrzej T; Bro?yna, Anna A; Skobowiat, Cezary et al. (2017) On the role of classical and novel forms of vitamin D in melanoma progression and management. J Steroid Biochem Mol Biol :
Slominski, Andrzej T; Kim, Tae-Kang; Hobrath, Judith V et al. (2017) Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols. Sci Rep 7:11434
Lin, Zongtao; Chen, Hao; Belorusova, Anna Y et al. (2017) 1?,20S-Dihydroxyvitamin D3 Interacts with Vitamin D Receptor: Crystal Structure and Route of Chemical Synthesis. Sci Rep 7:10193
Lin, Zongtao; Marepally, Srinivasa R; Ma, Dejian et al. (2016) Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23S-Dihydroxyvitamin D3 and Its 23R Epimer. J Med Chem 59:5102-8
Lin, Zongtao; Marepally, Srinivasa R; Kim, Tae-Kang et al. (2016) Design, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs. Anticancer Res 36:877-86
Xiao, Min; Li, Wei (2015) Recent Advances on Small-Molecule Survivin Inhibitors Curr Med Chem 22:1136 - 1146
Lin, Zongtao; Marepally, Srinivasa Reddy; Ma, Dejian et al. (2015) Chemical Synthesis and Biological Activities of 20S,24S/R-Dihydroxyvitamin D3 Epimers and Their 1?-Hydroxyl Derivatives. J Med Chem 58:7881-7
Xiao, Min; Wang, Jin; Lin, Zongtao et al. (2015) Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties. PLoS One 10:e0129807
Slominski, Andrzej T; Janjetovic, Zorica; Kim, Tae-Kang et al. (2015) Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation. J Steroid Biochem Mol Biol 148:52-63
Slominski, Andrzej T; Kim, Tae-Kang; Li, Wei et al. (2015) Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci Rep 5:14875

Showing the most recent 10 out of 28 publications